Quantcast
Last updated on April 20, 2014 at 19:30 EDT

Latest Bone marrow Stories

2011-11-04 05:57:09

(Ivanhoe Newswire) -- A new study shows older blood cancer patients should be able to receive stem cell transplants no matter what age group they are in— 60 to 64, 65 to 69 or 70 to 75. Patients in all three age groups had comparable survival rates, suggesting  age played a limited role in how patients tolerate the mini-transplant, a "kinder, gentler" form of allogeneic (donor cell) stem cell transplantation developed at Fred Hutchinson Cancer Research Center. "Age is no longer...

2011-11-01 15:04:08

Young environment rescues old stem cells for use in treating age-related diseases Old stem cells can be rejuvenated by being placed in a young microenvironment, research from The University of Texas Health Science Center San Antonio shows. This raises the possibility that patients´ own stem cells may one day be rescued and banked to treat their age-related diseases. Stem cells are immature cells that have the potential to convert into bone, muscle, blood vessels, nerve fibers, and...

2011-10-27 15:43:00

NEW ORLEANS, La., Oct. 27, 2011 /PRNewswire/ -- At only 16, Madison Tully faced the biggest challenge of her life -- a rare and deadly combination of lupus and sickle cell disease that caused her immune system to turn on her own body. She was at Tulane Medical Center last summer in debilitating pain as doctors proposed a possible cure. View the video: http://tulane.edu/empowers/bone_marrow.cfm However, the procedure -- a bone marrow transplant -- had never been attempted to treat both...

2011-10-17 08:15:00

NEW YORK, Oct. 17, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with a focus on cell-based therapeutic development, and Amorcyte Inc., a development stage cell therapy company focusing on novel treatments for cardiovascular disease, announced today the closing of their previously announced merger transaction following approval by the shareholders of both companies on October 14, 2011. NeoStem, which closed on a...

2011-10-07 12:19:08

Study published in the American Journal of Pathology Bone marrow-derived cells (BMDCs) participate in the growth and spread of tumors of the breast, brain, lung, and stomach. To examine the role of BMDCs, researchers developed a mouse model that could be used to track the migration of these cells while tumors formed and expanded. Their results, published in the November issue of The American Journal of Pathology, strongly suggest that more effective cancer treatments may be developed by...

2011-10-05 14:00:00

AUSTIN, Texas, Oct. 5, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that it has joined forces with the National Marrow Donor Program - Be The Match to raise awareness of the need for additional donors to increase the chances of finding a match for the growing number of patients awaiting life-saving bone marrow transplants. Recently, more than 100 Luminex employees joined the National Marrow Donor Registry in an effort to assist patients nationwide. Luminex will...

2011-09-27 10:36:16

Researchers in Japan have completed a study showing that stem cells derived from deciduous canine teeth and dental pulp can be grafted and produce bone regeneration between parents and offspring. Their results are published in the current issue of Cell Transplantation (20:7), now freely available on-line. "Bone defects can occur for a number of reasons, and autogenous bone grafting - using the patient's own bone - has been a standard approach to treatment," said study corresponding author...

2011-09-20 12:38:13

A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated.  Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents. Scientists didn´t have a plausible research-based answer until now, according to the UCSF researchers. In a paper published this month in the scientific journal...

2011-09-20 11:58:25

Stem cell technology from Tel Aviv University research begins clinical trial for Lou Gehrig's disease The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as...

2011-09-15 15:15:00

Help beat Ohio State and "Be a Hero at the Big House" Nov. 16 at U-M's largest drive for organ, blood, tissue and bone marrow donors ANN ARBOR, Mich., Sept. 15, 2011 /PRNewswire-USNewswire/ -- Tucker Schumacher was just a baby when his parents got the nightmarish news. Their little guy was very sick, and just to survive, he needed a crucial organ transplant. At 14 months old, little Tucker got a liver transplant at C.S. Mott Children's Hospital. Now he's 18, entering his senior year of...


Latest Bone marrow Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »